slotkoers
Korea S.E.
00:00:00 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
2.105
KRW
|
-0,24%
|
|
+1,94%
|
-37,72%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
631.931
|
491.644
|
566.198
|
345.966
|
244.105
|
124.245
|
Bedrijfswaarde
1 |
574.284
|
460.341
|
522.763
|
298.494
|
184.866
|
91.085
|
K/w-verhouding
|
-43
x
|
-28,6
x
|
-19,5
x
|
-11,7
x
|
-5,84
x
|
-4,48
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
1.572
x
|
1.202
x
|
278
x
|
4.704
x
|
1.132
x
|
944
x
|
Bedrijfswaarde/omzet
|
1.428
x
|
1.126
x
|
257
x
|
4.059
x
|
857
x
|
692
x
|
Bedrijfswaarde/EBITDA
|
-46,8
x
|
-28,1
x
|
-23,1
x
|
-9,85
x
|
-5,63
x
|
-3,51
x
|
Bedrijfswaarde/FCF
|
-66,2
x
|
-20
x
|
260
x
|
-9,95
x
|
-5,81
x
|
-5,87
x
|
FCF Yield
|
-1,51%
|
-5%
|
0,38%
|
-10,1%
|
-17,2%
|
-17%
|
Price to Book
|
8,15
x
|
7,83
x
|
9,73
x
|
5,11
x
|
2,78
x
|
2,06
x
|
Aantal aandelen (in duizenden)
|
21.791
|
21.916
|
22.588
|
23.219
|
36.763
|
36.759
|
Referentieprijs
2 |
29.000
|
22.433
|
25.067
|
14.900
|
6.640
|
3.380
|
Datum van publicatie
|
28/03/19
|
19/03/20
|
23/03/21
|
23/03/22
|
15/03/23
|
21/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
402
|
408,9
|
2.036
|
73,54
|
215,7
|
131,7
|
EBITDA
1 |
-12.263
|
-16.397
|
-22.591
|
-30.297
|
-32.815
|
-25.959
|
Bedrijfsresultaat (EBIT)
1 |
-13.728
|
-18.335
|
-24.888
|
-33.560
|
-36.733
|
-29.784
|
Operationele Marge
|
-3.414,59%
|
-4.484,32%
|
-1.222,23%
|
-45.632,96%
|
-17.032,78%
|
-22.622,84%
|
Resultaat voor belastingen (EBT)
1 |
-13.233
|
-17.131
|
-28.768
|
-29.575
|
-34.470
|
-28.342
|
Nettowinst (verlies)
1 |
-13.233
|
-17.131
|
-28.768
|
-29.257
|
-33.427
|
-27.718
|
Nettomarge
|
-3.291,6%
|
-4.189,82%
|
-1.412,78%
|
-39.782,05%
|
-15.499,53%
|
-21.054,04%
|
WPA
2 |
-673,9
|
-783,7
|
-1.286
|
-1.273
|
-1.137
|
-754,1
|
Free Cash Flow
1 |
-8.680
|
-23.028
|
2.009
|
-30.011
|
-31.797
|
-15.506
|
FCF-marge
|
-2.159,04%
|
-5.631,96%
|
98,67%
|
-40.807,94%
|
-14.744,09%
|
-11.777,71%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/03/19
|
19/03/20
|
23/03/21
|
23/03/22
|
15/03/23
|
21/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
57.647
|
31.303
|
43.435
|
47.473
|
59.240
|
33.160
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-8.680
|
-23.028
|
2.009
|
-30.011
|
-31.797
|
-15.506
|
ROE (netto-inkomsten/eigen vermogen)
|
-20,6%
|
-24,4%
|
-47,4%
|
-45,3%
|
-42,3%
|
-36,8%
|
ROA (netto-inkomsten/totale activa)
|
-12%
|
-14,2%
|
-17,1%
|
-19,1%
|
-21%
|
-21%
|
Totale activa
1 |
110.705
|
120.397
|
167.880
|
152.891
|
158.808
|
131.905
|
Nettoactief per aandeel
2 |
3.556
|
2.867
|
2.576
|
2.916
|
2.386
|
1.644
|
Cashflow per aandeel
2 |
1.551
|
310,0
|
1.359
|
1.303
|
1.083
|
825,0
|
Capex
1 |
3.037
|
13.115
|
5.657
|
5.048
|
1.826
|
100
|
Capex/omzet
|
755,4%
|
3.207,62%
|
277,79%
|
6.863,53%
|
846,87%
|
76,28%
|
Datum van publicatie
|
28/03/19
|
19/03/20
|
23/03/21
|
23/03/22
|
15/03/23
|
21/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -37,72% | 56,01 mln. | | -2,29% | 89,87 mld. | | -3,95% | 37,57 mld. | | -13,07% | 32,75 mld. | | +63,05% | 26,47 mld. | | -22,14% | 14,25 mld. | | -7,96% | 12,99 mld. | | -9,33% | 11,93 mld. | | -46,33% | 10,84 mld. | | +5,77% | 9,11 mld. |
Biofarmaceutica
|